Advanced Life Sciences Holdings, Inc. (NASDAQOTCBB:ADLS)

CAPS Rating: No stars

A biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, oncology and inflammation.

Results 1 - 1 of 1


Member Avatar JohnnyLC (46.03) Submitted: 5/29/2008 8:32:04 PM : Outperform Start Price: $2.20 ADLS Score: -139.51

Phase III results for Cethromycin looks good. Company planning on NDA submits in 3Q of this year but need a partnership to cover the 10M cost owned to Abbott upon filing of NDA. Company is undervalued right now but it all comes down to how good of a partnership deal they can negotiate. PPS has dropped low enough for me to make a gamble.

Results 1 - 1 of 1

Featured Broker Partners